Research programme: TEAD inhibitors - Sporos BioDiscovery
Latest Information Update: 16 Jun 2023
At a glance
- Originator Sporos BioDiscovery
- Class Antineoplastics; Small molecules
- Mechanism of Action TEA domain transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer